A guide to antibiotic resistance in bacterial skin infections

The emergence of bacterial resistance to commonly used antibiotics is not new. In this review we have tried to cover the ever increasing problems facing the treatment and containment of bacterial skin infections. We have tried to give an overview of the varied mechanisms by which bacteria gain and spread antimicrobial resistance, whilst dealing with the patterns of resistance exhibited by some of the commonly encountered organisms. Where there is evidence, we have formulated an approach on how to tackle antibiotic resistance. Where there is a lack of evidence we have formulated what we perceive to be appropriate guidelines.

[1]  S. Iida,et al.  A single gene coding for resistance to both fusidic acid and chloramphenicol. , 1982, Journal of molecular biology.

[2]  T. Yamauchi,et al.  Enterococcal infections. , 1993, Pediatrics in review.

[3]  R. Skurray,et al.  Molecular evolution of multiply-antibiotic-resistant staphylococci. , 2007, Ciba Foundation symposium.

[4]  W. James,et al.  Microbiology of the skin: resident flora, ecology, infection. , 1989, Journal of the American Academy of Dermatology.

[5]  Y. Asada,et al.  The Incidence of Isolation of Methicillin‐resistant Staphylococcus aureus (MRSA) Strains from Skin Infections during the Past Three Years (1989–1991) , 1993, The Journal of dermatology.

[6]  M. E. Villarino.  Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus; principles of therapy and revised recommendations , 1998 .

[7]  T. Uchiyama,et al.  Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Strains Causing Neonatal Toxic Shock Syndrome-Like Exanthematous Disease in Neonatal and Perinatal Wards , 2003, Journal of Clinical Microbiology.

[8]  M. Ma.  Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. , 1994 .

[9]  J. Romero,et al.  Fatal coagulase-negative staphylococci infection after bone marrow transplantation in a patient with persistent adverse reactions to vancomycin. , 1999, Journal of pediatric hematology/oncology.

[10]  C. Kunin,et al.  Resistance to Antimicrobial DrugsA Worldwide Calamity , 1993, Annals of Internal Medicine.

[11]  T. Joint.  Chemotherapy and management of tuberculosis in the United Kingdom : recommendations 1998 Joint Tuberculosis , 1998 .

[12]  D. Calfee,et al.  Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Sáez-Nieto,et al.  A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. , 1995, The Journal of antimicrobial chemotherapy.

[14]  W. Agger,et al.  Pseudomonas aeruginosa infections of intact skin. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Bonnetblanc,et al.  [Methi-resistant Staphylococcus aureus in dermatological practice: origin, risk factors and outcome]. , 2002, Annales de dermatologie et de venereologie.

[16]  J. Travis,et al.  Reviving the antibiotic miracle? , 1994, Science.

[17]  T. Riley,et al.  Mupirocin‐resistant methicillin‐resistant Staphylococcus aureus in Western Australia , 1994, The Medical journal of Australia.

[18]  J. Meis,et al.  Prevalence of Vancomycin-Resistant Enterococci in Europe , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[19]  E. H. Montgomery,et al.  Principles of anti-infective therapy. , 1984, Dental clinics of North America.

[20]  E. Colt.  Inactivation of Antibiotics and the Dissemination of Resistance Genes , 2001 .

[21]  J. Cove,et al.  Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. , 1996, The Journal of antimicrobial chemotherapy.

[22]  W. Cunliffe,et al.  Tetracycline‐resistant propionibacteria from acne patients are cross‐resistant to doxycycline, but sensitive to minocycline , 1993, The British journal of dermatology.

[23]  J. Liñares,et al.  The VISA/GISA problem: therapeutic implications. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  E. Brown,et al.  Fusidic acid resistance in Staphylococcus aureus isolates , 2002, The Lancet.

[25]  B. Cookson.  Mupirocin resistance in staphylococci. , 1990, The Journal of antimicrobial chemotherapy.

[26]  M. Cormican,et al.  Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae. , 1996, Diagnostic microbiology and infectious disease.

[27]  D. Hutchinson.  Oxazolidinone antibacterial agents: a critical review. , 2003, Current topics in medicinal chemistry.

[28]  J. Paladino.  Linezolid: an oxazolidinone antimicrobial agent. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[29]  D. Livermore,et al.  Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. , 2004, The Journal of antimicrobial chemotherapy.

[30]  J. Cove,et al.  The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin resistant propionibacteria , 1996, The British journal of dermatology.

[31]  Fred C Tenover,et al.  Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. , 2003, The New England journal of medicine.

[32]  D. Feingold.  Bacterial Adherence, Colonization, and Pathogenicity , 1986 .

[33]  E. Kaplan,et al.  In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. , 1994, The Pediatric infectious disease journal.

[34]  M. Enright,et al.  Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages , 2004, Emerging infectious diseases.

[35]  J. Weinberg,et al.  Cutaneous Tuberculosis , 2002, American journal of clinical dermatology.

[36]  J. Cove,et al.  Short‐term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema , 2003, British Journal of Dermatology.

[37]  D. Leigh,et al.  Treatment of familial staphylococcal infection--comparison of mupirocin nasal ointment and chlorhexidine/neomycin (Naseptin) cream in eradication of nasal carriage. , 1993, The Journal of antimicrobial chemotherapy.

[38]  H. Eagle.  Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. , 1952, The American journal of medicine.

[39]  G. French.  Safety and tolerability of linezolid. , 2003, The Journal of antimicrobial chemotherapy.

[40]  E. Heir,et al.  Characterization of class I integrons in clinical strains of Salmonella enterica subsp. enterica serovars Typhimurium and Enteritidis from Norwegian hospitals. , 2003, Journal of medical microbiology.

[41]  B. Eisenstein.  Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections , 2004, Expert opinion on investigational drugs.

[42]  E. Giovanetti,et al.  Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci , 2001, The Lancet.

[43]  B. Spratt.  Resistance to antibiotics mediated by target alterations. , 1994, Science.

[44]  Bacteriology , 1926, Nature.

[45]  M. Mohanraj,et al.  High levels of fusidic acid‐resistant Staphylococcus aureus in dermatology patients , 2003, The British journal of dermatology.

[46]  Y. Hirakata,et al.  Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. , 2002, The Journal of antimicrobial chemotherapy.

[47]  Abeck,et al.  Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications , 1998, The British journal of dermatology.

[48]  T. Horio,et al.  The effect of antibiotics on the production of superantigen from Staphylococcus aureus isolated from atopic dermatitis. , 2002, Journal of dermatological science.

[49]  C. O. Solberg.  Spread of Staphylococcus aureus in Hospitals: Causes and Prevention , 2000, Scandinavian journal of infectious diseases.

[50]  B. Mason,et al.  Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing. , 2003, The Journal of antimicrobial chemotherapy.

[51]  K. T. Holland,et al.  Inhibition of erythromycin‐resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc , 1994, The British journal of dermatology.

[52]  R. A. Myers,et al.  The microbiology of necrotizing soft tissue infections. , 2000, American journal of surgery.

[53]  D. Hougaard,et al.  erm genes in erythromycin‐resistant Staphylococcus aureus and coagulase‐negative staphylococci , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[54]  K. D. Allen,et al.  Hexachlorophane powder and neonatal staphylococcal infection. , 1994, The Journal of hospital infection.

[55]  J. Blumer,et al.  Skin and soft tissue infections: pharmacologic approaches , 1985, Pediatric infectious disease.

[56]  C. Connolly,et al.  Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa. , 1999, AIDS.

[57]  F. Taddei,et al.  Plasmids spread very fast in heterogeneous bacterial communities. , 2002, Genetics.

[58]  J. Leyden,et al.  Propionibacterium acnes Resistance: A Worldwide Problem , 2003, Dermatology.

[59]  C. Brun-Buisson,et al.  Comparison of Systematic Versus Selective Screening for Methicillin-Resistant Staphylococcus aureus Carriage in a High-Risk Dermatology Ward , 2000, Infection Control & Hospital Epidemiology.

[60]  J. Meyerhoff.  Single-dose doxycycline prevented Lyme disease after an Ixodes scapularis tick bite. , 2002, ACP journal club.

[61]  Megan E. Pahmier,et al.  Double Blind , 2001, International Psychogeriatrics.

[62]  G. Rusul,et al.  Conjugal transfer of plasmids and antibiotic resistance among Escherichia coli isolated from animals in a rural area in Sarawak (Malaysia) , 1997, Journal of applied microbiology.

[63]  J. Leyden,et al.  The skin microflora in acne vulgaris. , 1974, The Journal of investigative dermatology.

[64]  M. Kaufmann,et al.  Emerging Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Two Austrian Patients in the Same Intensive Care Unit , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[65]  K. Harding,et al.  Investigating the bacterial barrier properties of four contemporary wound dressings. , 2000, Journal of wound care.

[66]  A. Kligman.  An overview of acne. , 1974, The Journal of investigative dermatology.

[67]  C. Kunin,et al.  Resistance to antimicrobial drugs--a worldwide calamity. , 1993, Annals of internal medicine.

[68]  P. Marazzi,et al.  Clinical evaluation of Double Strength Isotrexin™ versus Benzamycin ® in the topical treatment of mild to moderate acne vulgaris , 2002, The Journal of dermatological treatment.

[69]  S. Normark,et al.  Evolution and spread of antibiotic resistance , 2002, Journal of internal medicine.

[70]  A. Nilius.  Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class. , 2003, Current opinion in investigational drugs.

[71]  C. Sanders,et al.  beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  H. J. Kolmos,et al.  Coagulase-negative Staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility. , 1996, The Journal of hospital infection.

[73]  G. Saunders.  Methicillin resistant Staphylococcus aureus. , 2006, The West Indian medical journal.

[74]  Christine C. Sanders,et al.  β-Lactam Resistance in Gram-Negative Bacteria: Global Trends and Clinical Impact , 1992 .

[75]  G. Wormser,et al.  Erythromycin Resistance in Borrelia burgdorferi , 2002, Antimicrobial Agents and Chemotherapy.

[76]  Pulmonary Infections.  Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children , 1998 .

[77]  T. Yamagishi,et al.  Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects , 1999, International journal of dermatology.

[78]  S. Barrett,et al.  Trying to control MRSA causes more problems than it solves. , 1998, The Journal of hospital infection.

[79]  S. Levy,et al.  Heterogeneity of tetracycline resistance determinants. , 1980, Plasmid.

[80]  Ronald N. Jones,et al.  Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) , 1998, Antimicrobial Agents and Chemotherapy.

[81]  M. A. Gerber.  Antibiotic resistance in group A streptococci. , 1995, Pediatric clinics of North America.

[82]  K. T. Holland,et al.  The use of antibiotics in acne therapy: oral or topical administration? , 1982, The Journal of antimicrobial chemotherapy.

[83]  R. Daum,et al.  Antimicrobial resistance in staphylococci. , 1995, Pediatric clinics of North America.

[84]  K. D. Allen,et al.  Epidemiology of penicillin-resistant pneumococci in a Merseyside Health District over a 14-year period. , 2003, The Journal of infection.

[85]  T. Nakae,et al.  An Elegant Means of Self-protection in Gram-negative Bacteria by Recognizing and Extruding Xenobiotics from the Periplasmic Space* 210 , 2003, The Journal of Biological Chemistry.

[86]  G. Ayliffe,et al.  The effect on the skin flora of bathing with antiseptic solutions. , 1977, Journal of Antimicrobial Chemotherapy.

[87]  E. Eady,et al.  Antibiotic resistance patterns of aerobic coryneforms and furazolidone-resistant Gram-positive cocci from the skin surface of the human axilla and fourth toe cleft. , 2000, The Journal of antimicrobial chemotherapy.

[88]  C. Watanakunakorn,et al.  Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. , 1995, American journal of infection control.

[89]  M. Hodson,et al.  CIPROFLOXACIN-RESISTANT PSEUDOMONAS , 1985, The Lancet.

[90]  M. Pfaller,et al.  Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). , 1999, Diagnostic microbiology and infectious disease.

[91]  N. Saunders.  Vancomycin administration and monitoring reappraisal. , 1995, The Journal of antimicrobial chemotherapy.

[92]  A. Cheng,et al.  Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. , 1990, The Journal of hospital infection.

[93]  Y. Fukuchi,et al.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin , 1997, The Lancet.

[94]  A. Kligman,et al.  Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes , 2002, The Journal of dermatological treatment.

[95]  T. D. Read,et al.  Role of Mobile DNA in the Evolution of Vancomycin-Resistant Enterococcus faecalis , 2003, Science.

[96]  Fernando Baquero,et al.  Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance , 2002, Clinical Microbiology Reviews.

[97]  M. Simmonds,et al.  Two novel assays for the detection of haemin-binding properties of antimalarials evaluated with compounds isolated from medicinal plants. , 2002, The Journal of antimicrobial chemotherapy.

[98]  Cox.  Streptococcal necrotizing fasciitis and the dermatologist , 1999, The British journal of dermatology.

[99]  P. Morley,et al.  A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis. , 1988, Current medical research and opinion.

[100]  Savitri Sharma,et al.  Ciprofloxacin-resistant Pseudomonas keratitis. , 1999, Ophthalmology.

[101]  K. Scott.  The role of conjugative transposons in spreading antibiotic resistance between bacteria that inhabit the gastrointestinal tract , 2002, Cellular and Molecular Life Sciences CMLS.

[102]  K. Nash.  Effect of Drug Concentration on Emergence of Macrolide Resistance in Mycobacterium avium , 2001, Antimicrobial Agents and Chemotherapy.

[103]  H. Neu,et al.  The Crisis in Antibiotic Resistance , 1992, Science.

[104]  R. Darouiche,et al.  Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin , 1991, Antimicrobial Agents and Chemotherapy.

[105]  R. Kirsner,et al.  Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. , 1998, Archives of dermatology.

[106]  A. Cooper.  Systematic review of Propionibacterium acnes resistance to systemic antibiotics , 1998, The Medical journal of Australia.

[107]  S. Wallander,et al.  Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres. , 1990, Scandinavian journal of infectious diseases.

[108]  J. Hamilton-miller,et al.  Methicillin-resistant Staphylococcus aureus. , 1989, The New England journal of medicine.

[109]  M. Louie,et al.  Screening High-Risk Patients for Methicillin-Resistant Staphylococcus Aureus on Admission to the Hospital Is It Cost Effective? , 1999, Infection Control & Hospital Epidemiology.

[110]  J. Garau,et al.  Importance of dose and duration of beta-lactam therapy in nasopharyngeal colonization with resistant pneumococci. , 2002, The Journal of antimicrobial chemotherapy.

[111]  Wilkinson.  Fusidic acid in dermatology , 1998, The British journal of dermatology.

[112]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.